Recurrence phenomena after immunoglobulin therapy for snake envenomations: Part 2. Guidelines for clinical management with crotaline fab antivenom

Annals of Emergency Medicine

Volumn 37, Issue 2, 2001, Pages 196-201

  Boyer, Leslie V ^a,b   Seifert, Steven A ^a,b   Cain, Jeffrey S ^a,b  

^a UNIVERSITY OF ARIZONA   (United States)

^b CARL R DARNALL ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROFAB; IMMUNOGLOBULIN ANTIBODY; MONOCROTALINE; SNAKE VENOM ANTISERUM;

BLOOD CLOTTING DISORDER; CONFERENCE PAPER; ENVENOMATION; FOLLOW UP; HIGH RISK PATIENT; HUMAN; IMMUNOTHERAPY; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SNAKEBITE;

EID: 0035134542     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2001.113134     Document Type: Conference Paper

References (35)

1. Purpura following timber rattlesnake (Crotalus horridus horridus) envenomation
2. Fibrinogenolytic afibrinogenemia after envenomation by Western diamondback rattlesnake (Crotalus atrox)
3. Blood platelet studies in man and rabbits following Crotalus envenomation
4. Relationship of venom e effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom
5. Recurrent and persistent coagulopathy following pit viper envenomation
6. First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: Randomized comparative trial with Institute Pasteur serum (IPSER) Africa antivenom
7. Recurrence of local symptoms of crotalid envenomation in ovine Fab antivenom treated patients
8. Prevention and treatment of recurrent local symptoms in crotalid envenomation treated with ovine Fab
9. Envenomation by the Northern blacktail rattlesnake 9. (Crotalus rnolossus rnolossus): Report of two cases and the in vitro effects of the venom on fibrinolysis and platelet aggregation
10. Recurrent coagulopathy after antivenom treatment of Crotalid snakebite
11. Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled viper (Echis 'pyramidum'-complex): Failure of antivenom treatment
12. Clinical significance of venom antigen levels in patients envenomed by the Malayan pit viper (Calloselasrna rhodostorna)
13. A critical reappraisal of the use of enzyme-linked immunosorbent assays in the study of snakebite
14. Envenoming by the common krait (Bungarus caeruleus) and Sri Lankan cobra (Naja naja naja): Efficacy and complications of therapy with Haffkine antivenom
15. Antivenom treatment in Vipera berus envenoming - Report of 30 cases
16. Pharmacokinetics of three commercial antivenoms in patients envenomed by the Malayan pit viper, Calloselasma rhodostoma, in Thailand
17. Affinity-purified, mixed monospecific Crotalid antivenom ovine Fab for the treatment of Crotalid venom poisoning
18. The treatment of crotalid envenomation without Antivenin
19. Death from a rattlesnake bite
20. Mechanism of defibrination in humans after envenomation by the eastern diamondback rattlesnake
21. Poisonous snakebite: A review. 1. Snakes and their venom
22. Defibrination by Agkistrodon rhodostoma venom
23. Hemostatic aspects of envenomation by North American snakes
24. The quantitative relation between platelet count and hemorrhage in patients with acute leukemia
25. Incidence of thrombocytopenia and serious hemorrhage among patients with solid tumors
26. Congenital afibrinogenemia
27. Fibrinogen abnormalities
28. Other coagulation factor deficiencies
29. Bleeding complications to oral anticoagulant therapy: Multivariate analysis of 1010 treatment years in 551 outpatients
30. Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy
31. Hemorrhagic complications of anticoagulant treatment
32. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage
33. A comparison of low molecular weight heparin with unfractionated heparin for unstable coronary artery disease